drugset / Trial / NCT00175513
V3: Vancouver-Victoria Valacyclovir Trial for Early Psychosis
Phase 2
Completed
100 enrolled
University of British Columbia
Stanley Medical Research Institute · collab
RandomizedSingle-groupOpen-labelTreatment
Summary
This is an 18 week (2 weeks run-in, 16 weeks double blind) trial, to determine if an antiviral drug, valacyclovir (Valtrex) is helpful in treating the symptoms of psychosis, a form of a mental disorder.
Timeline
- Start
- 2005-09
- Primary completion
- 2009-09
- Completion
- 2009-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Valacyclovir | Unknown | — | — |